Welcome to our dedicated page for SmartKem SEC filings (Ticker: SMTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SmartKem, Inc. filings document the public-company record for an organic semiconductor technology developer with common stock listed on Nasdaq under SMTK. The filings cover material-event reports, Securities Act registration statements, notices about annual-report timing, and disclosures tied to its advanced-materials and transistor-backplane business.
Recent regulatory documents address material definitive agreements, convertible notes, preferred stock financings, warrants, private placements, resale registration matters, Nasdaq listing-compliance disclosures, officer and subsidiary governance changes, shareholder voting matters, operating and financial results, and capital-structure updates involving common stock, preferred stock, and warrant securities.
The Board of SmartKem, Inc. is soliciting proxies for the virtual Annual Meeting of Stockholders to be held on (Record Date: ) for holders of Common Stock. Agenda items include election of two Class II directors, advisory votes on executive compensation and frequency, ratification of CBIZ CPAS P.C., and multiple charter and equity-related amendments.
Notable proposals: increase authorized common shares from 300,000,000 to 5,000,000,000; increase 2021 Equity Incentive Plan shares from 1,643,692 to 2,144,622; authorize up to two reverse stock split amendments; and approvals related to below‑Nasdaq‑minimum issuances tied to an Equity Line of Credit and conversion of Series A preferred/warrants.
SmartKem, Inc. funded a $2,300,000 convertible bridge loan to Ferrox Critical Minerals, earning a $200,000 origination fee and 5% annual interest until October 30, 2026. The loan is documented by a Convertible Promissory Note.
If Ferrox defaults, the interest rate increases to 15% and SmartKem becomes entitled to a $4,500-per-day default management fee. SmartKem can convert the debt into Ferrox ordinary shares at the lower of fair market value or a price based on an $80,000,000 fully‑diluted equity value.
The Note includes restrictive covenants on Ferrox’s ability to take on debt, pay dividends, or dispose of assets, and grants SmartKem a right of first refusal and exclusivity through October 30, 2026 on major equity, debt, or change‑of‑control “Fundamental Transactions.”
SmartKem, Inc. registers 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants.
The prospectus states the company is not selling any shares for its own account and will not receive proceeds from resales by the selling stockholders, although SmartKem will receive net proceeds from any warrants exercised for cash. The filing summarizes related financings including an equity line purchase agreement providing up to $500,000,000 or 19.99% of outstanding shares (whichever is less), senior secured notes with an original principal of $3,750,000 and related security interests, and a settlement involving a $300,000 cash payment and assignment of certain patents.
SmartKem, Inc. registers up to 146,776,707 shares of common stock for resale by Keystone Capital Partners, LLC under a March 30, 2026 Purchase Agreement. These shares may be issued to Keystone at the Company's discretion and then resold by Keystone. The Purchase Agreement includes a maximum committed purchase of up to $500 million or 19.99% of outstanding common stock at the time of the agreement, subject to Nasdaq limits and other conditions. The prospectus states the Company will not receive proceeds from resales by Keystone via this registration, though the Company may receive proceeds if it elects to sell shares to Keystone under the Purchase Agreement.
SmartKem, Inc. announced that a Nasdaq Hearings Panel has determined the company has regained compliance with the stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(2) and meets all other criteria for continued listing on The Nasdaq Capital Market.
The company still has until September 1, 2026 to regain compliance with the minimum bid price requirement in Nasdaq Listing Rule 5550(a)(2). SmartKem will also be under a one-year Discretionary Panel Monitor, meaning any new compliance failure during this period could trigger an immediate delisting determination, though the company would be able to appeal and request a new hearing.
SmartKem, Inc. filed an amended current report to correct details of its recent Series A preferred stock financing. The amendment clarifies that investors received warrants to purchase up to 24,542,982 shares of common stock and that the warrant exercise price is $0.5812 per share.
The filing also reiterates that the company agreed in a private placement to sell 11,411.5 shares of newly designated Series A Convertible Preferred Stock, each with a stated value of $1,000. These preferred shares are convertible into common stock at an initial conversion price of $0.5812 per share, subject to adjustment under the related certificate of designations.
SmartKem, Inc. reported that on April 10, 2026 it accepted the voluntary resignation of Simon Ogier as Chief Technology Officer of subsidiary SmartKem Ltd., effective April 13, 2026. The company stated that his resignation is not due to any dispute or disagreement over financial statements, internal controls, operations, policies, or practices.
SmartKem, Inc. is registering 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of newly designated Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants. The company itself is not selling shares here and will not receive proceeds from resales; however, SmartKem will receive net proceeds from any Warrants exercised for cash. The prospectus discloses an equity line with Keystone allowing up to $500,000,000 or 19.99% of outstanding shares (reduced by certain issuances), a senior secured notes financing with original principal $3,750,000 (issued at a ~30% discount), and related settlement and patent assignments tied to prior notes.